Nisa Investment Advisors’s Kura Oncology KURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.49K | Hold |
183
| – | – | ﹤0.01% | 2668 |
|
|
2025
Q4 | $1.9K | Sell |
183
-940
| -84% | -$9.86K | ﹤0.01% | 2615 |
|
|
2025
Q3 | $9.94K | Buy |
1,123
+149
| +15% | +$1.06K | ﹤0.01% | 2283 |
|
|
2025
Q2 | $5.62K | Sell |
974
-822
| -46% | -$5.04K | ﹤0.01% | 2425 |
|
|
2025
Q1 | $11.9K | Buy |
1,796
+806
| +81% | +$6.28K | ﹤0.01% | 2057 |
|
|
2024
Q4 | $8.62K | Sell |
990
-146
| -13% | -$2.1K | ﹤0.01% | 2166 |
|
|
2024
Q3 | $22.2K | Buy |
1,136
+12
| +1% | +$243 | ﹤0.01% | 1882 |
|
|
2024
Q2 | $23.1K | Buy |
1,124
+64
| +6% | +$1.32K | ﹤0.01% | 1895 |
|
|
2024
Q1 | $22.6K | Buy |
1,060
+70
| +7% | +$1.36K | ﹤0.01% | 1849 |
|
|
2023
Q4 | $14.2K | Buy |
990
+16
| +2% | +$157 | ﹤0.01% | 1962 |
|
|
2023
Q3 | $8.88K | Sell |
974
-15
| -2% | -$152 | ﹤0.01% | 2194 |
|
|
2023
Q2 | $10.5K | Sell |
989
-1,336
| -57% | -$15.8K | ﹤0.01% | 2250 |
|
|
2023
Q1 | $28K | Buy |
2,325
+1,385
| +147% | +$17.3K | ﹤0.01% | 1901 |
|
|
2022
Q4 | $12K | Sell |
940
-53
| -5% | -$770 | ﹤0.01% | 2169 |
|
|
2022
Q3 | $15K | Sell |
993
-2,297
| -70% | -$35.4K | ﹤0.01% | 2112 |
|
|
2022
Q2 | $60K | Buy |
3,290
+1,470
| +81% | +$21.1K | ﹤0.01% | 1676 |
|
|
2022
Q1 | $29K | Buy |
1,820
+1,220
| +203% | +$17.6K | ﹤0.01% | 1977 |
|
|
2021
Q4 | $8K | Hold |
600
| – | – | ﹤0.01% | 2054 |
|
|
2021
Q3 | $11 | Hold |
600
| – | – | ﹤0.01% | 2192 |
|
|
2021
Q2 | $13 | Sell |
600
-2,250
| -79% | -$55.9K | ﹤0.01% | 2192 |
|
|
2021
Q1 | $81 | Sell |
2,850
-375
| -12% | -$11.9K | ﹤0.01% | 1839 |
|
|
2020
Q4 | $105K | Buy |
3,225
+1,075
| +50% | +$37.8K | ﹤0.01% | 1716 |
|
|
2020
Q3 | $66K | Buy |
+2,150
| New | +$47.5K | ﹤0.01% | 1695 |
|
Other funds holding KURA
SCM
BI
VCM
AC
PM
DTC
